SE7608771L - Forfarande for framstellning av extrakt ur det hematopoetiska systemet - Google Patents

Forfarande for framstellning av extrakt ur det hematopoetiska systemet

Info

Publication number
SE7608771L
SE7608771L SE7608771A SE7608771A SE7608771L SE 7608771 L SE7608771 L SE 7608771L SE 7608771 A SE7608771 A SE 7608771A SE 7608771 A SE7608771 A SE 7608771A SE 7608771 L SE7608771 L SE 7608771L
Authority
SE
Sweden
Prior art keywords
chalones
leucocytes
extracts
hemopoietic
granulocytic
Prior art date
Application number
SE7608771A
Other languages
English (en)
Swedish (sv)
Inventor
W A Jones
T L S T H Yuen
T Rytomaa
N J Harper
H F Frost
Original Assignee
Union International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union International Co Ltd filed Critical Union International Co Ltd
Publication of SE7608771L publication Critical patent/SE7608771L/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7608771A 1975-08-05 1976-08-04 Forfarande for framstellning av extrakt ur det hematopoetiska systemet SE7608771L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32659/75A GB1579120A (en) 1975-08-05 1975-08-05 Extracts of the haemopoietic system

Publications (1)

Publication Number Publication Date
SE7608771L true SE7608771L (sv) 1977-02-06

Family

ID=10342062

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608771A SE7608771L (sv) 1975-08-05 1976-08-04 Forfarande for framstellning av extrakt ur det hematopoetiska systemet

Country Status (19)

Country Link
US (1) US4294824A (2)
JP (1) JPS5218807A (2)
AR (1) AR211931A1 (2)
AU (1) AU515950B2 (2)
BE (1) BE844875A (2)
CA (1) CA1063019A (2)
DE (1) DE2635065C2 (2)
DK (1) DK350876A (2)
FI (1) FI762178A7 (2)
FR (1) FR2320106A1 (2)
GB (1) GB1579120A (2)
IE (1) IE44378B1 (2)
IN (1) IN144537B (2)
IT (1) IT1062655B (2)
LU (1) LU75535A1 (2)
NL (1) NL7608651A (2)
NZ (1) NZ181653A (2)
SE (1) SE7608771L (2)
ZA (1) ZA764643B (2)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
JPS6339609Y2 (2) * 1980-11-21 1988-10-18
JPS59141520A (ja) * 1983-02-02 1984-08-14 Kyowa Hakko Kogyo Co Ltd Dna合成抑制物質
DE69334178T2 (de) * 1992-12-04 2008-08-07 Toray Industries, Inc. Dialysemembran für Herstellung von Inhibitor der Blutbildung enthaltende Zusammensetzungen
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
AU706857B2 (en) * 1995-12-21 1999-06-24 Genzyme Corporation Method for lysing cells
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
DE69920209T2 (de) 1998-03-26 2005-10-06 Viranative Ab Verfahren zur kontinuierlichen reinigung und konzentrierung von leukozyten aus dem blut
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
DE102004047262A1 (de) * 2004-09-24 2006-04-06 Ipss International Pharmaceutical Strategies & Solutions Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen
US20060067942A1 (en) * 2004-09-24 2006-03-30 Salama Zoser B Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals
EP1640012A1 (de) * 2004-09-24 2006-03-29 Salama, Zoser B. nat.rer.Dr. Pharmazeutisches Mittel enthaltend Blutbestandteile 10 kDa und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems
RU2278675C1 (ru) * 2005-01-17 2006-06-27 Юрий Борисович Иванов Антимикробное средство и фармацевтическая композиция, содержащая эффективное количество антимикробного средства
RU2304978C2 (ru) * 2005-07-14 2007-08-27 Георгий Михайлович Элбакидзе Средство тканеспецифического регулирования митохондриальных процессов и его применение при лечении заболеваний (варианты)

Also Published As

Publication number Publication date
ZA764643B (en) 1978-03-29
IE44378B1 (en) 1981-11-04
GB1579120A (en) 1980-11-12
IE44378L (en) 1977-02-05
BE844875A (fr) 1977-02-04
IT1062655B (it) 1984-10-20
AU515950B2 (en) 1981-05-14
NZ181653A (en) 1979-01-11
DE2635065A1 (de) 1977-02-17
DK350876A (da) 1977-02-06
US4294824A (en) 1981-10-13
FI762178A7 (2) 1977-02-06
DE2635065C2 (de) 1983-10-27
AU1661476A (en) 1978-02-09
AR211931A1 (es) 1978-04-14
IN144537B (2) 1978-05-13
LU75535A1 (2) 1978-02-13
NL7608651A (nl) 1977-02-08
JPS5218807A (en) 1977-02-12
CA1063019A (en) 1979-09-25
FR2320106B1 (2) 1980-11-07
FR2320106A1 (fr) 1977-03-04

Similar Documents

Publication Publication Date Title
SE7608771L (sv) Forfarande for framstellning av extrakt ur det hematopoetiska systemet
DK368283A (da) Fremgangsmaade til udvinding af rene krystallinske anhydropentitoler, mono- og/eller dianhydrohexitoler
MX169362B (es) Procedimiento de obtencion de un extracto antioxidante de especias
AR228060A1 (es) Procedimiento de preparacion de membrana de fibra hueca porosa para la separacion de plasma
EP0180452A3 (en) Three-phase irradiation blood-treatment process
NO873885L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter.
ES2051737T3 (es) Antigenos, anticuerpos y metodos para la identificacion de tumores humanos metastasicos, y lineas celulares para producir dichos anticuerpos.
MX5960E (es) Procedimiento para la preparacion de concentrados altamente purificados del complejo protrombinico
URUSHIZAKI et al. Immunosuppressive factors in serum of patients with gastric carcinoma
Kuo et al. Subcellular distribution of ascorbic acid in rat brain
MX161477A (es) Procedimiento para extraer los constituyentes de la manzanilla
ES502084A0 (es) Procedimiento para tratar fracciones individuales de plasma sanguineo.
NL169337C (nl) Werkwijze voor de bereiding van vormmassa's van macromoleculaire thermoplastische polycarbonaten, alsmede daarvan vervaardigd gevormd voortbrengsel.
KR910000172A (ko) 남미의 거머리인 헤멘테리아 길리아니로부터의 항전이 물질길란텐
DK49783A (da) Fremgangsmaade til fremstilling af panthenolderivater
Dagenais Speech training with glossometry and palatometry for profoundly hearing-impaired children.
Cozad Speechreading skill and communication difficulty of children and young adults with unilateral hearing loss.
EP0141939A3 (de) Verfahren zur Herstellung von natürlichem Immunoadsorbens
JPS5538336A (en) Extraction of hypotensive substance
JPS57155991A (en) Preparation of superoxide dismutase derived from human placenta
GB904803A (en) Process for the manufacture of a waterproof cape
JPS53115660A (en) Method for treating juice
Singh et al. Role of anxiety and intelligence in the performance of a simple psychomotor task by the rural and urban college students.
GB1532946A (en) Aloe product and a process for the preparation thereof
Erwin To what degree was Freud wrong—and how much difference does it make in psychotherapy?

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7608771-7